Expression and function of B cell specific MB-1 protein associated with IgM receptor
与 IgM 受体相关的 B 细胞特异性 MB-1 蛋白的表达和功能
基本信息
- 批准号:05454209
- 负责人:
- 金额:$ 4.67万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
B cell antigent receptor is composed of antigen specific membrane IgM molecule and its associated proteins of MB-1 (Ig-alpha, CD79a) and B29 (Ig-beta, CD79b) .This basic structure is essential not only for the expression of B cell antigen receptor on the surface of B lymphocytes but also for signal transduction of stimulatory signal given by antigen. Within cytoplasmic domains of MB-1 and B29, there are antigen recognition consensus motif that can bind to various functional components related to the signal transduction. B cell antigen receptor complex involves src-type tyrosine kinase Lyn, Fyn, Lck, Blk, non src-tyupe tyrosine kinase Syk, and PI-3 kinase. Crosslinking of antigen receptor induces signal transduction of phosphatidyl inositol patyways, leading to the increase of intracellular Ca mobilization and protein kinase sctivity. It also induces signal transduction of ras-MECK/MAPK pathway leading to activation of nuclear transcription factors. Activation to antigen receptor on B cells also induces PI-3 kinase activity which then probably mediates important signal for the proliferation and differentiation of B cells.Regardless of these fundamental findings concerning to B cell signal transduction pathways, little is known about the mechanism and quality of signal transduction through these signal transduction pathways in different stages of B lineage cells. To clearly identify novel molecules involved in the B cell antigen receptor complex, we searched for the functional phosphoprotein molecules associated with MB-1 protein. A 52 kDa protein is coprecipitated with anti-MB-1 protein. We prepared rat monoclonal antibody against this 52 kDa protein and isolated a candidate cDNA clone named alpha4 with this monoclonal antibody. The alpha4 cDNA clone is a new molecule which is tightly associated with kinase molecules in B cells, which is located in the down stream of the signal transduction through B cell antigen raceptor.
B细胞抗原受体由抗原特异性膜IgM分子及其相关蛋白MB-1 (ig - α, CD79a)和B29 (ig - β, CD79b)组成。这一基本结构不仅对B淋巴细胞表面B细胞抗原受体的表达至关重要,而且对抗原给予的刺激信号的信号转导也至关重要。在MB-1和B29的细胞质结构域内,存在抗原识别共识基序,可以结合与信号转导相关的各种功能成分。B细胞抗原受体复合物包括src型酪氨酸激酶Lyn、Fyn、Lck、Blk、非src型酪氨酸激酶Syk和PI-3激酶。抗原受体的交联诱导磷脂酰肌醇途径的信号转导,导致细胞内Ca动员和蛋白激酶活性的增加。它还可以诱导ras-MECK/MAPK通路的信号转导,从而激活核转录因子。B细胞抗原受体的活化还可诱导PI-3激酶活性,从而可能介导B细胞增殖和分化的重要信号。尽管有这些关于B细胞信号转导途径的基本发现,但对B系细胞不同阶段通过这些信号转导途径进行信号转导的机制和质量知之甚少。为了清楚地识别参与B细胞抗原受体复合物的新分子,我们寻找了与MB-1蛋白相关的功能性磷酸化蛋白分子。52kda蛋白与抗mb -1蛋白共沉淀。我们制备了抗该52 kDa蛋白的大鼠单克隆抗体,并分离了一个候选cDNA克隆,命名为alpha4。alpha4 cDNA克隆是B细胞中与激酶分子紧密相关的新分子,位于B细胞抗原受体信号转导的下游。
项目成果
期刊论文数量(64)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sakaguchi,N.: "Immunoglobulin receptor(IgR)-associated molecules." Advances in Immunology. 54. 337-392 (1993)
Sakaguchi,N.:“免疫球蛋白受体(IgR)相关分子。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nomura,J.: "Anti-CD40 monoclonal antibody induces the proliferation of murine B cells as a B cell mitogen through a distinct pathway from receptors for antigens or lipopolysaccharide." Immunology Letters. (in press).
Nomura, J.:“抗 CD40 单克隆抗体作为 B 细胞有丝分裂原,通过与抗原或脂多糖受体不同的途径诱导小鼠 B 细胞增殖。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kuwahara,K.: "Identification of a 52-kDa molecule(p52)co-precipitated with the immunoglobulin receptor-related MB-1 protein which is inducibly phosphorylated by the stimulation with phorbol myristate acetate" J.Immunol.(印刷中).
Kuwahara, K.:“鉴定与免疫球蛋白受体相关的 MB-1 蛋白共沉淀的 52 kDa 分子 (p52),该蛋白通过佛波醇肉豆蔻酸酯乙酸酯的刺激而诱导磷酸化”J.Immunol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Melchers,F.: "The surrogate light chain in B cell development." Immunology Today. 14. 60-68 (1993)
Melchers,F.:“B 细胞发育中的替代轻链。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Inui,S.: "Signal transduction through B cell specific molecule MB-1 in early lymphoid progenitor cells." Leucocyte Typing V White Cell Differentiation Antigens. (印刷中).
Inui, S.:“早期淋巴祖细胞中 B 细胞特异性分子 MB-1 的信号转导。”白细胞分型 V 白细胞分化抗原(正在出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAKAGUCHI Nobuo其他文献
Servival of antigen-derived germinal center B-cell is controlled by centrocyte-associated expression of apoptosis-regulator G5PR.
抗原衍生的生发中心 B 细胞的存活由细胞凋亡调节因子 G5PR 的中心细胞相关表达控制。
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
KITABATAKE Masahiro;TODA Teppei;KUWAHARA Kazuhiro;IGARASHI Hideya;OHTSUJI Mareki;HIROSE Sachiko;SAKAGUCHI Nobuo - 通讯作者:
SAKAGUCHI Nobuo
SAKAGUCHI Nobuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAKAGUCHI Nobuo', 18)}}的其他基金
Role of the RNA-primase GANP in cancer development
RNA引物酶 GANP 在癌症发展中的作用
- 批准号:
17013069 - 财政年份:2005
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
An experimental mouse model of spontaneous generation of HodgkinDisease by introduction of GANP RNA-primase gene
通过引入 GANP RNA 引物酶基因建立自发发生霍奇金病的实验小鼠模型
- 批准号:
15023248 - 财政年份:2003
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Study of B cell antigen receptor (BCR)-mediated signal transduction pathway
B细胞抗原受体(BCR)介导的信号转导通路研究
- 批准号:
10470087 - 财政年份:1998
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of immature B cell activation and differentiation
未成熟 B 细胞活化和分化分析
- 批准号:
07457088 - 财政年份:1995
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Expression and function of B cell specific MB-1 protein associated with IgM receptor
与 IgM 受体相关的 B 细胞特异性 MB-1 蛋白的表达和功能
- 批准号:
02454192 - 财政年份:1990
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
I-Corps: Chimeric Antigen Receptor T Cell Manufacturing for Cancer Therapies
I-Corps:用于癌症治疗的嵌合抗原受体 T 细胞制造
- 批准号:
2403974 - 财政年份:2024
- 资助金额:
$ 4.67万 - 项目类别:
Standard Grant
Improving Chimeric Antigen Receptor (CAR) T-Cell Therapy Using Engineering Biology and Mechanobiological Approach
利用工程生物学和力学生物学方法改进嵌合抗原受体 (CAR) T 细胞疗法
- 批准号:
10074571 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
Grant for R&D
Development of canine chimeric antigen receptor-T cell that converts exhaustion-inducing signals into activation signals
开发犬嵌合抗原受体 T 细胞,将疲劳诱导信号转化为激活信号
- 批准号:
22KJ2967 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Delineating mechanisms underlying the enhanced stability and functionality of CD2-KO Tregs and chimeric antigen receptor (CAR) Tregs and their application in xenotransplantation
描述 CD2-KO Tregs 和嵌合抗原受体 (CAR) Tregs 稳定性和功能增强的机制及其在异种移植中的应用
- 批准号:
10646753 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
ICF: Chimeric antigen receptor T cells targeting CD123, CD33 and CLL1 for therapy of Acute Myeloid Leukaemia
ICF:靶向 CD123、CD33 和 CLL1 的嵌合抗原受体 T 细胞用于治疗急性髓系白血病
- 批准号:
MR/X03030X/1 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
Research Grant
Development of novel combination therapy of chimeric antigen receptor T cells and HMG-CoA reductase inhibitors (statin)
嵌合抗原受体T细胞和HMG-CoA还原酶抑制剂(他汀类药物)的新型联合疗法的开发
- 批准号:
23K15306 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
strategic research and development of chimeric antigen receptor T cell therapy in solid tumors
实体瘤嵌合抗原受体T细胞疗法的战略研发
- 批准号:
23K06783 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of chimeric antigen receptor T cells using antibodies derived from colon cancer tumor-associated B cells.
使用源自结肠癌肿瘤相关 B 细胞的抗体生成嵌合抗原受体 T 细胞。
- 批准号:
23K15473 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Optimizing outcomes for children and young adults with relapse of B-cell acute lymphoblastic leukemia after CD19-targeted chimeric antigen receptor T-cell therapy
优化 CD19 靶向嵌合抗原受体 T 细胞治疗后 B 细胞急性淋巴细胞白血病复发的儿童和年轻人的结局
- 批准号:
10572071 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy
使用 mRNA-外泌体工程体内嵌合抗原受体巨噬细胞 (CARM) 用于癌症免疫治疗
- 批准号:
10740743 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别: